*.- Breast cancer cells are more sensitive to Trabectedin as compared to MCF-10A cells.
*.- Trabectedin induces apoptotic cell death in MCF-7 and MDA-MB-453 breast cancer cells.
*.- Trabectedin activates the death receptor mediated apoptotic pathway in MCF-7 cells.
*.- Trabectedin activates the mitochondria mediated apoptotic pathway in MDA-MB-453 cells.
*.- Trabectedin induces reactive oxygen species generation in both breast cancer cells.
*.- We have shown that trabectedin causes selective activation of extrinsic and intrinsic apoptotic pathways in two genotypically different breast cancer cells.
*- This preliminary data might guide clinicians to choose appropriate combination agents with trabectedin based on different molecular subtypes of breast cancer.
...